Evidence map›Paper›PMID 25376173›Full record

ArticleJournal of ovarian research2014

Uterine mast cell tumor: a clinical and cytohistopathological study.

Ali Mohammad Bahrami, Fariba Khaki, Shahram Zehtabian, Javad Cheraghi, Mehdi Rashnavadi, Mohammad Reza Hafezi Ahmadi, Mostafa Naderafif, Soheil Javaherypour, Siamak Mohsenzadeh, Ehsan Hosseini and 2 more

RetractedOpen access · goldAbstract readCase ReportsRetracted Publication
In one paragraph

Article in Journal of ovarian research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Ali Mohammad BahramiFaculty of Para Veterinary Medicine, Ilam University, Ilam, Iran. am.bahrami@ilam.ac.ir.
Fariba KhakiDepartment of Pathology, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran. fkhaki@yahoo.com.
Shahram ZehtabianDepartment of Microbiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. shzehtabian@gmail.com.
Javad CheraghiDepartment of Physiology, Faculty of Para Veterinary Medicine, Ilam University, Ilam, Iran. j.cheraghi@mail.ilam.ac.ir.
Mehdi RashnavadiFaculty of Para Veterinary Medicine, Ilam University, Ilam, Iran. m.rashnavadi@yahoo.com.
Mohammad Reza Hafezi AhmadiDepartment of Pathology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran. Hafezi-m@medilam.ac.ir.
Mostafa NaderafifDepartment of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran. mnaderafif@yahoo.com.
Soheil JavaherypourStudent of Veterinary Medicine, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran. Soli1998@gmail.com.
Siamak MohsenzadehDepartment of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran. siamak_2000iran@yahoo.com.
Ehsan HosseiniDepartment of Physiology, Faculty of Para Veterinary Medicine, Ilam University, Ilam, Iran. Hosseiniehsan460@gmail.com.
Hamed MasoudiStudent of Veterinary Medicine, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran. Hamedmasoudi1992@gmail.com.
Mehdi PourzaerDepartment of Pathology, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran. mehdi.p1981@gmail.com.
Ilam University · IRFerdowsi University of Mashhad · IRUniversity of Tehran · IRUrmia University · IRKermanshah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMast cells are one of the characteristic factors in angiogenesis, growth, and metastatic spread of tumors. Further studies are suggested to determine the type of these cells which might be useful in the assessment of biological nature of the tumor and its future treatment modality. Few studies have evaluated mast cell infiltration in visceral tumors, especially uterine tumors. CASE PRESENTATION: In this study, age, sex, death rate, and histologic patterns were in agreement with those of previous reports on canine mast cell tumors. Cytopathology assays are widely used to prognosticate canine uterine mast cell tumors (MCT). There is limited information about these prognostic assays used on MCT that arise in the uterine. The anisocytosis and anisocytosis and giant cells were present in the tumor. Furthermore, the tumor had nuclear atypia with scattered multinucleated cells and prominent nucleoli and tumor were classified as poorly granulated. Under microscopic examination, we observed diffuse infiltration and proliferation of tumor cells from the uterine different area and the infiltrative characteristics and distribution patterns of neoplastic cells were observed. This tumor consisted of sheets and cords of uniform round cells with discrete cytoplasmic margins. Microscopically, the neoplastic masses were poorly-demarcated and lacked capsules and tumor cell usually showed a distinct cell boundary. Nevertheless, the neoplastic cells were located between collagen bundles forming small clusters and sheets and had large, centrally located, round to ovoid nuclei. In addition, eosinophils were scattered among the mast cells at the periphery of the masses. The presence of eosinophils and the observation, at high magnification, of cells with cytoplasmic metachromatic granules.

conclusionBased on these findings, a diagnosis of poorly-differentiated mast cell tumor was made and data histologic grading was available for tumor. Neoplasm was poorly differentiated or gradeIII.

Indexed as

AnimalsDog DiseasesDogsFemaleMastocytosisUterine Neoplasms

Identifiers

PMID25376173
PMCPMC4243290
OpenAlexW2112751977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.